ATE261432T1 - Verfahren zur herstellung von 4-phenyl-1,2,3,6- tetrahydropyridin-derivaten und die dafür verwendeten zwischenprodukte - Google Patents

Verfahren zur herstellung von 4-phenyl-1,2,3,6- tetrahydropyridin-derivaten und die dafür verwendeten zwischenprodukte

Info

Publication number
ATE261432T1
ATE261432T1 AT99401497T AT99401497T ATE261432T1 AT E261432 T1 ATE261432 T1 AT E261432T1 AT 99401497 T AT99401497 T AT 99401497T AT 99401497 T AT99401497 T AT 99401497T AT E261432 T1 ATE261432 T1 AT E261432T1
Authority
AT
Austria
Prior art keywords
phenyl
reacting
compound
formula
agent
Prior art date
Application number
AT99401497T
Other languages
English (en)
Inventor
Francis Brion
Christian Richard
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE261432T1 publication Critical patent/ATE261432T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
AT99401497T 1998-06-18 1999-06-17 Verfahren zur herstellung von 4-phenyl-1,2,3,6- tetrahydropyridin-derivaten und die dafür verwendeten zwischenprodukte ATE261432T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9807677A FR2780056B1 (fr) 1998-06-18 1998-06-18 Nouveau procede de preparation de derives de la 4-phenyl-1-2 3,6-tetrahydropyridine et les produits imtermediaires mis en oeuvre

Publications (1)

Publication Number Publication Date
ATE261432T1 true ATE261432T1 (de) 2004-03-15

Family

ID=9527532

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99401497T ATE261432T1 (de) 1998-06-18 1999-06-17 Verfahren zur herstellung von 4-phenyl-1,2,3,6- tetrahydropyridin-derivaten und die dafür verwendeten zwischenprodukte

Country Status (11)

Country Link
US (1) US6136981A (de)
EP (1) EP0965588B1 (de)
JP (1) JP4538114B2 (de)
AT (1) ATE261432T1 (de)
CA (1) CA2275192C (de)
DE (1) DE69915413T2 (de)
DK (1) DK0965588T3 (de)
ES (1) ES2213991T3 (de)
FR (1) FR2780056B1 (de)
HU (1) HU225621B1 (de)
PT (1) PT965588E (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5981747B2 (ja) * 2012-03-28 2016-08-31 東ソー・ファインケム株式会社 アザディールス−アルダー反応用触媒、それを用いたテトラヒドロピリジン化合物の製造方法
BR112017022666A8 (pt) 2015-04-20 2022-10-18 Tolero Pharmaceuticals Inc Preparando resposta à alvocidib por perfilamento mitocondrial
CN111349118B (zh) 2015-05-18 2023-08-22 住友制药肿瘤公司 具有增加的生物利用度的阿伏西地前药
RU2759963C2 (ru) 2015-08-03 2021-11-19 Сумитомо Даиниппон Фарма Онколоджи, Инк. Комбинированные терапии для лечения рака
US11279694B2 (en) 2016-11-18 2022-03-22 Sumitomo Dainippon Pharma Oncology, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
JP6619519B2 (ja) 2016-12-19 2019-12-11 トレロ ファーマシューティカルズ, インコーポレイテッド プロファイリングペプチドおよび感受性プロファイリングのための方法
WO2019055579A1 (en) 2017-09-12 2019-03-21 Tolero Pharmaceuticals, Inc. TREATMENT REGIME FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBITORS USING THE MCL-1 ALVOCIDIB INHIBITOR
MX2021006544A (es) 2018-12-04 2021-07-07 Sumitomo Pharma Oncology Inc Inhibidores de cinasa dependiente de ciclina 9 (cdk9) y polimorfos de los mismos para uso como agentes para el tratamiento de cancer.
JP2022525149A (ja) 2019-03-20 2022-05-11 スミトモ ダイニッポン ファーマ オンコロジー, インコーポレイテッド ベネトクラクスが失敗した急性骨髄性白血病(aml)の処置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2338043A1 (fr) * 1976-01-13 1977-08-12 Delmar Chem Derives de 4-arylpiperidine et procedes de production
US4132710A (en) * 1976-12-20 1979-01-02 Ayerst, Mckenna And Harrison, Ltd. [2]Benzopyrano[3,4-c]pyridines and process therefor
US5849733A (en) * 1996-05-10 1998-12-15 Bristol-Myers Squibb Co. 2-thio or 2-oxo flavopiridol analogs
US6268499B1 (en) * 1998-08-10 2001-07-31 Hoffman-La Roche Inc. Process and intermediates for preparation of substituted piperidine-epoxides

Also Published As

Publication number Publication date
JP2000026418A (ja) 2000-01-25
EP0965588B1 (de) 2004-03-10
US6136981A (en) 2000-10-24
DE69915413T2 (de) 2004-08-19
PT965588E (pt) 2004-07-30
HUP9902040A2 (hu) 2001-11-28
FR2780056A1 (fr) 1999-12-24
ES2213991T3 (es) 2004-09-01
HU225621B1 (en) 2007-05-02
CA2275192C (fr) 2008-12-30
HU9902040D0 (en) 1999-08-30
JP4538114B2 (ja) 2010-09-08
EP0965588A1 (de) 1999-12-22
CA2275192A1 (fr) 1999-12-18
FR2780056B1 (fr) 2000-08-04
DE69915413D1 (de) 2004-04-15
DK0965588T3 (da) 2004-06-21

Similar Documents

Publication Publication Date Title
ATE254612T1 (de) Zuckerderivate, geliermittel, geliermittelzubereitungen, verfahren zu ihrer herstellung und gelzubereitungen
DE69638035D1 (de) Verfahren zur Herstellung substituierter 1,1,1-Trifluoro-3-buten-2-one
AU2381695A (en) Intermediates in pharmaceutical camptothecin preparation
HU9203761D0 (en) Method for producing substituted pyridine derivatives
ATE261432T1 (de) Verfahren zur herstellung von 4-phenyl-1,2,3,6- tetrahydropyridin-derivaten und die dafür verwendeten zwischenprodukte
ATE241594T1 (de) N-phenylacetoacetamide und verfahren zu ihrer herstellung
ATE138376T1 (de) Verfahren zur herstellung von benzylphthalazinonderivaten und von deren salzen
DE69839732D1 (de) Verfahren zur herstellung von 3,4-dihydroxy-3cyclobuten-1,2-dion
PL349933A1 (en) Novel compounds beta-hydroxyalylamides, method of obtaining them and their application
ATE270287T1 (de) 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme
ATE127449T1 (de) Anilinderivate und verfahren zu ihrer herstellung.
ATE554094T1 (de) Verfahren zur herstellung von 3-cephem- verbindungen
DE69007203D1 (de) Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel.
ATE103598T1 (de) Verfahren zur herstellung von zwischenprodukten in der synthese von diltiazem.
ATE172964T1 (de) Verfahren zur herstellung von (-)-n-methyl-n-(4- (4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4- dichlorophenyl)butyl>-benzamid und ihr pharmazeutisch annehmbares salz
ATE205178T1 (de) Verfahren zur herstellung von 3,4-dihydroxy-3- cyclobuten-1,2-dion
DK0521766T3 (da) Hidtil ukendt fremgangsmåde til syntese af enantiomerer af 3-aminochromanderivater
ATE223377T1 (de) Verfahren zur herstellung von difluoracetophenon- derivaten
ATE407118T1 (de) Verfahren zur herstellung von n-alkoxycarbonyl- piperidin derivaten sowie zwischenverbindungen dafür
ATE225350T1 (de) Verfahren zur herstellung von folsäure
DE69615570D1 (de) Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten
ATE256096T1 (de) Verfahren zur herstellung von 2- arylvinylalkylethern und 1,4-diaryl-2-fluor-2- butenen
ATE253048T1 (de) Verfahren zur herstellung von piperidincarbonsäureamiden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0965588

Country of ref document: EP